(Q77765859)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Detection of ErbB2 oversignalling in a majority of breast cancers with phosphorylation-state-specific antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

X Ouyang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

T Gulliford

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Doherty

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

G C Huang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R J Epstein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

353

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

9164

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1591-1592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2901095-8

7 January 2021

Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2901095-8

7 January 2021

Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2901095-8

7 January 2021

Adjacent carboxyterminal tyrosine phosphorylation events identify functionally distinct ErbB2 receptor subsets: implications for molecular diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2901095-8

7 January 2021

Human cancer cells exhibit protein kinase C-dependent c-erbB-2 transmodulation that correlates with phosphatase sensitivity and kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2901095-8

7 January 2021

10.1016/S0140-6736(99)01095-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334266%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference